The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Parkinson’s UK award a multi-million dollar grant to ...

PrimeRX announced the launch of a new platform aimed at pharmacies named PrimeRX MARKET. 1 This platform will provide users ...

The company announced that it has partnered with Adena Health and The Ohio State University Health Plan Solutions. Digital ...

Funding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage ...

Kisunla is the first amyloid plaque-targeting therapy that allows for stopping treatment upon plaque removal, company says.

NeuroSense announced further data from its PARADIGM Phase 2b study. 1 The new data was derived from a 12-month analysis of ...

Robert A. Michael has assumed the role of CEO at AbbVie. 1 He has replaced Richard A. Gonzalez, who stepped down from the ...

Approval of both NRX-101 and NRX-100 could potentially yield more than $150 in revenue per NRXP share in the near term, ...

How pharmaceutical companies can utilize AI at key stages of the treatment journey to enhance patient-centric engagement by ...

After years of collaborating with hospitals, Magnolia Medical has launched a new digital platform designed to prevent sepsis ...

Reportedly, the liquid formulation of Tepylute eliminates the need for complex and time-consuming reconstitution, providing ...

Approval of Epkinly was based on results from the Phase I/II EPCORE trial in patients with relapsed or refractory follicular ...